Business Standard

India coronavirus dispatch: Long road to recovery for discharged patients

Schools, colleges are likely to stay shut, to looking at the plight of migrant workers who stayed back in Delhi, to the long road to recovery for discharged patients

India coronavirus dispatch: Long road to recovery for discharged patients
Premium

Cipla Ltd and Hetero Drugs have got authorisations for antiviral remdesivir for restricted emergency use

Sarah Farooqui New Delhi
Schools, colleges likely to stay shut, the new medicines for restricted use, and why only science can combat the virus, — a roundup of articles in Indian news publications on how India is dealing with the Covid-19 pandemic.

Expertspeak

Not all Covid-19 patients need antivirals. New drugs for restricted use at physicians’ discretion: Cipla Ltd and Hetero Drugs have got authorisations for antiviral remdesivir for restricted emergency use, and Glenmark Pharmaceuticals, has got an approval for manufacture and marketing antiviral favipiravir. These medicines are likely to be available in the hands of medical professionals who are fighting Covid-19. How

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in